The Exchange has received the revised disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Basaboini Malathi & PACs
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Samsrita Labs Ltd received a revised SAST disclosure from Basaboini Malathi and three Persons Acting in Concert (PACs) — all confirmed as non-promoters. They were allotted 15,00,000 equity shares (6.6% of total share capital) via preferential allotment on 18.07.2025. Basaboini Malathi and Mallikarjun Rao Basaboini each got 5,00,000 shares (2.20% each), while Mrinalini Basaboini and Mriganayani Basaboini each got 2,50,000 shares (1.10% each). Their combined holding moved from 0% to 6.6%, crossing the 5% disclosure threshold. The company's total equity capital expanded from about 1.48 crore to 2.27 crore shares, suggesting this was part of a wider preferential issue.
A new non-promoter group has built a 6.6% stake via preferential allotment, indicating fresh capital infusion into the company. Existing shareholders should note the equity dilution and watch for further disclosures, as this group is now above the 5% reporting mark and could add to their holding.